| P50 | author | Carlos Palacio | Q83011236 |
| | Francesc Bosch | Q53260145 |
| | Marta Crespo | Q42037673 |
| | Josep Castellvi | Q42648101 |
| P2093 | author name string | Pau Abrisqueta | |
| | Noelia Purroy | |
| | Cecilia Carpio | |
| | Eva Calpe | |
| | Júlia Carabia | |
| P2860 | cites work | Abdominal computed tomography predicts progression in patients with Rai stage 0 chronic lymphocytic leukemia. | Q53495440 |
| | A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment. | Q54592043 |
| | ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. | Q55036524 |
| | CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential | Q61640131 |
| | CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphoma | Q74198916 |
| | Signaling through ZAP-70 is required for CXCL12-mediated T-cell transendothelial migration | Q77975029 |
| | Homeostatic chemokines increase survival of B-chronic lymphocytic leukemia cells through inactivation of transcription factor FOXO3a | Q80319155 |
| | ZAP-70 expression is associated with enhanced ability to respond to migratory and survival signals in B-cell chronic lymphocytic leukemia (B-CLL) | Q81583965 |
| | Reproducible establishment of hemopoietic supportive stromal cell lines from murine bone marrow | Q42816695 |
| | Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia | Q43119715 |
| | Recruitment of PKC-betaII to lipid rafts mediates apoptosis-resistance in chronic lymphocytic leukemia expressing ZAP-70. | Q43243964 |
| | Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia | Q44189675 |
| | Down-regulation of CXCR4 and CD62L in chronic lymphocytic leukemia cells is triggered by B-cell receptor ligation and associated with progressive disease. | Q44214843 |
| | Distinct role of ZAP-70 and Src homology 2 domain-containing leukocyte protein of 76 kDa in the prolonged activation of extracellular signal-regulated protein kinase by the stromal cell-derived factor-1 alpha/CXCL12 chemokine | Q44484570 |
| | ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia. | Q44605532 |
| | ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia | Q44859885 |
| | ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia | Q46112511 |
| | ZAP-70 enhances B-cell-receptor signaling despite absent or inefficient tyrosine kinase activation in chronic lymphocytic leukemia and lymphoma B cells. | Q51119490 |
| | CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells. | Q53336736 |
| | BCR ligation induced by IgM stimulation results in gene expression and functional changes only in IgV H unmutated chronic lymphocytic leukemia (CLL) cells. | Q53476669 |
| | ZAP-70: a 70 kd protein-tyrosine kinase that associates with the TCR zeta chain | Q24294340 |
| | Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia | Q24599100 |
| | A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1) | Q24677007 |
| | Targeting CD37-positive lymphoid malignancies with a novel engineered small modular immunopharmaceutical | Q24681992 |
| | BCR ligation reprograms B cells for migration to the T zone and B-cell follicle sequentially | Q28204940 |
| | In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells | Q33830733 |
| | The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo | Q34029869 |
| | Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia ("accelerated" chronic lymphocytic leukemia) with aggressive clinical behavior | Q34095636 |
| | The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia | Q34249777 |
| | A combination of cytokines rescues highly purified leukemic CLL B-cells from spontaneous apoptosis in vitro | Q34653811 |
| | Role of the microenvironment in chronic lymphocytic leukaemia | Q35583432 |
| | Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha | Q35847913 |
| | B cell antigen receptor engagement inhibits stromal cell-derived factor (SDF)-1alpha chemotaxis and promotes protein kinase C (PKC)-induced internalization of CXCR4. | Q36368196 |
| | ZAP-70 enhances IgM signaling independent of its kinase activity in chronic lymphocytic leukemia | Q36478480 |
| | B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406. | Q37028635 |
| | Gene expression profiling reveals differences in microenvironment interaction between patients with chronic lymphocytic leukemia expressing high versus low ZAP70 mRNA | Q37207766 |
| | The microenvironment in mature B-cell malignancies: a target for new treatment strategies | Q37563816 |
| | Xenograft models of chronic lymphocytic leukemia: problems, pitfalls and future directions | Q38049970 |
| | ZAP-70 enhances migration of malignant B lymphocytes toward CCL21 by inducing CCR7 expression via IgM-ERK1/2 activation | Q39485051 |
| | Effective therapy of human lymphoma xenografts with a novel recombinant ribonuclease/anti-CD74 humanized IgG4 antibody immunotoxin | Q40383626 |
| | Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells. | Q40420056 |
| | Chronic lymphocytic leukemia cells receive RAF-dependent survival signals in response to CXCL12 that are sensitive to inhibition by sorafenib | Q41763842 |
| | Isoform-selective phosphoinositide 3'-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell-mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approach | Q42191925 |
| | Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migration | Q42221150 |
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | B-cell | Q188930 |
| P304 | page(s) | e81221 | |
| P577 | publication date | 2013-12-03 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | ZAP-70 promotes the infiltration of malignant B-lymphocytes into the bone marrow by enhancing signaling and migration after CXCR4 stimulation | |
| P478 | volume | 8 | |